Structure and conformation of N-(2-methyl-5-chlorophenyl)salicylaldimine
-
Add time:07/23/2019 Source:sciencedirect.com
N-(2-methyl-5-chlorophenyl)salicylaldimine (C14H12ClNO) has been studied by X-ray analysis and AM1 molecular orbital methods. It crystallises in the orthorhombic space group P212121 with a = 7.474(1) Å, b = 12.155(1) Å, c = 13.378(1) Å, V = 1215.3(2) Å3, Z = 4, Dc = 1.343 g cm−3 and μ(Mo Kα) = 0.296 mm−1. The structure was solved by direct methods and refined to R = 0.0374 for 1689 reflections [I > 2σ(I)]. The title compound is photochromic and the molecule is not planar. There is a strong intramolecular hydrogen bond of distance 2.604(3) Å between the hydroxyl oxygen atom and imine nitrogen atom, the hydrogen atom essentially being bonded to the oxygen atom. Minimum energy conformations from AM1 were calculated as a function of the three torsion angles θ1(C8N1C7C6), θ2(C9C8N1C7) and θ3(N1C7C6C5), varied every 10°. The optimised geometry of the crystal structure corresponding to a non-planar conformation is the most stable conformation in all calculations.
We also recommend Trading Suppliers and Manufacturers of N-(2-Methyl-5-chlorophenyl)-4,5-dihydro-1H-imidazole-2-amine (cas 16822-85-8). Pls Click Website Link as below: cas 16822-85-8 suppliers
Prev:The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation
Next:Formation of reactive oxygen species upon interaction of Au/ZnO with H2O2 and their activity in methylene blue degradation) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- The P-glycoprotein inhibitor diltiazem-like 8-(4-chlorophenyl)-5-methyl-8-[(2Z)-pent-2-en-1-yloxy]-8H-[1,2,4]oxadiazolo[3,4-c][1,4]thiazin-3-one inhibits esterase activity and H3 histone acetylation07/22/2019
- Synthesis, crystal structure analysis, spectral investigations (NMR, FT-IR, UV), DFT calculations, ADMET studies, molecular docking and anticancer activity of 2-(1-benzyl-5-methyl-1H-1,2,3-triazol-4-yl)-4-(2-chlorophenyl)-6-methoxypyridine – A novel potent human topoisomerase IIα inhibitor07/20/2019


